Study into conolidine has resulted in discovery of an opioid receptor in the body called ACKR3/CXCR7. ACKR3 appears to be the most popular target for conolidine, which also disregards the other 4 classical opioid receptors(3). Sign in as a member to master when there is medical evidence displaying a https://hughg677cqa2.ziblogs.com/profile